Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 39.75
-0.55 (-1.36%)
Feb 2, 2026, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 30.09 billion as of January 30, 2026. Its market cap has decreased by -3.67% in one year.
Market Cap
30.09B
Enterprise Value
33.46B
Revenue
1.57B
Ranking
n/a
PE Ratio
17.70
Stock Price
39.75
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 30.09B, an increase of 8,303.37%. That is a compound annual growth rate of 23.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 30.09B | -3.13% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 94.94B |
| Bora Pharmaceuticals Co., LTD. | 74.79B |
| TTY Biopharm Company | 21.21B |
| ScinoPharm Taiwan | 19.49B |
| Alar Pharmaceuticals | 18.00B |
| Grape King Bio | 17.92B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.84B |